Cargando…
Ailanthone: A novel potential drug for treating human cancer
Cancer is the second leading cause of death after cardiovascular disease. In 2015, >8.7 million people died worldwide due to cancer, and by 2030 this figure is expected to increase to ~13.1 million. Tumor chemotherapy drugs have specific toxicity and side effects, and patients can also develop se...
Autores principales: | Ding, Haixiang, Yu, Xiuchong, Hang, Chen, Gao, Kaijun, Lao, Xifeng, Jia, Yangtao, Yan, Zhilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377054/ https://www.ncbi.nlm.nih.gov/pubmed/32724391 http://dx.doi.org/10.3892/ol.2020.11710 |
Ejemplares similares
-
Ailanthone suppresses the activity of human colorectal cancer cells through the STAT3 signaling pathway
por: Ding, Haixiang, et al.
Publicado: (2022) -
Reduced expression of circRNA hsa_circ_0067582 in human gastric cancer and its potential diagnostic values
por: Yu, Xiuchong, et al.
Publicado: (2019) -
Linc-ROR Regulates POU5F1 and SOX2 by Competitively Binding miR-145-5p to Affect the Proliferation and Migration of Gastric Cancer Cells
por: Yu, Xiuchong, et al.
Publicado: (2023) -
Ailanthone: a new potential drug for castration-resistant prostate cancer
por: Peng, Shihong, et al.
Publicado: (2017) -
Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value
por: Yu, Xiuchong, et al.
Publicado: (2020)